Emerging Topics in Liver Disease Conference: Innovative Trends in Liver Health 2022 - LIVESTREAM (VIRTUAL ONLY)

September 17, 2022

LIVESTREAM (virtual) attendance

The epidemic of liver disease has become increasingly more common and poses complex problems regarding diagnosis and management. There are recent advances in the diagnosis and management of patients with liver disease. This CE activity has been designed to educate attendees about new developments in hepatology, and new approaches to management of liver diseases that can be readily integrated into their daily practice. A group of national experts, including several renowned guest faculty, will present new findings in a clinical context that will be beneficial in the multidisciplinary management of unique and complex liver disorders.

FEES

REGISTRATION TYPEFEE
Physician (Houston Methodist)$25
Physician (Private physician located within the Greater Houston Area)$300
Physician (Private physician located outside the Greater Houston Area)$50
Allied Health Care Professional$10
Resident / Fellow / StudentFree

Click Here to View Brochure

Target Audience

This conference is designed for primary care physicians, internists, hepatologists, gastroenterologists, oncologists, nurses, nurse practitioners, and physician assistants and other health care providers.

Learning Objectives

At the conclusion of this activity, the participant should be able to: 

  • Explain the current diagnosis and management of complications of portal hypertension and metabolic liver diseases
  • Identify emerging trends in fatty liver disease and determine the latest concepts in diagnosis and management
  • Provide significant information regarding new and critical developments in chronic HBV, HCV and COVID-19 liver involvement
  • Discuss current new developments and treatment of liver cancer – an emerging epidemic
Course summary
Available credit: 
  • 8.50 AMA PRA Category 1 Credit

    Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    Houston Methodist designates this Live activity for a maximum of 8.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 8.50 Attendance
  • 8.66 Nursing Contact Hours

    Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

    Houston Methodist will award 8.66 Nursing Continuing Professional Development contact hours for this activity. Participants must attend the activity in its entirety and complete the continuing education evaluation.

  • 8.00 Social Work
    The program has been approved for 8.00 CE contact hours for Social Workers through the Texas State Board of Social Work Examiners.
  • 8.00 Transplant Coordinators
    The American Board for Transplant Certification (ABTC) has assigned the following Continuing Education Points for Transplant Certification (CEPTCs) to the following Houston Methodist Transplant Center educational program: Emerging Topics in Liver Disease Conference: Innovative Trends in Liver Health 2022 - LIVESTREAM (VIRTUAL ONLY) | Thu, 05/12/2022 - 10:00am | 8.00 Category 1 CEPTCs
Course opens: 
05/12/2022
Course expires: 
11/01/2022
Event starts: 
09/17/2022 - 7:00am CDT
Event ends: 
09/17/2022 - 5:05pm CDT
Cost:
$300.00
TIMEPRESENTATIONSPEAKER(S)
7:00 AMRegistration and Breakfast 
7:20 AMWelcomeVictor Ankoma-Sey, MD, FACP, FAASLD
7:25 AMIntroductionR. Mark Ghobrial, MD, PhD, FACS, FRCS (Ed)
 Plenary Session I: Unique Complications of Chronic Liver Diseases
Moderators: Chukwuma Egwim, MD; Joseph S. Galati, MD; Ashish Saharia, MD, FACS
7:30 AMSherilyn Gordon-Burroughs State-of-Art-Lecture I
Acute-on-Chronic Liver Failure: Where Are We Now? 
Hugo E. Vargas, MD
8:00 AMHepatorenal Syndrome: Pathogenesis, Current and Future Therapies Florence Wong, MD, FRACP, FRCPC
8:30 AMWhat is New in Hepatic Encephalopathy? Jasmohan S. Bajaj, MBBS, MD, MSc, FACG, AGAF, FAASLD, FRCP
9:00 AMState of the Art Lecture I
The Unique Challenges in the Management of Viral Hepatitis B and C in the Immunocompromised Patient 
Norah A. Terrault, MD, MPH, FAASLD
9:30 AMQuestion and Answer / Case Discussions – Putting it into PracticeChukwuma Egwim, MD; Joseph S. Galati, MD; Ashish Saharia, MD, FACS
9:50 AMBreak and Exhibits
 Plenary Session II: Advances in Non-Alcoholic Fatty Liver Disease - What is New?
Moderators: Victor Ankoma-Sey, MD, FACP, FAASLD; Constance M. Mobley, MD, PhD, FACS; David W. Victor, III, MD
10:05 AMEpidemiology, Pathogenesis and Natural History: 2022 UpdateDavid W. Victor, III, MD
10:35 AMNoninvasive Assessment in Nonalcoholic Fatty Liver DiseaseMazen Noureddin, MD, MHSc
11:05 AMState of the Art Lecture II
Current and Future Treatment Options
Naga P. Chalasani, MD
11:35 AMQuestion and Answer / Case Discussions – Putting it into PracticeVictor Ankoma-Sey, MD, FACP, FAASLD; Constance M. Mobley, MD, PhD, FACS; David W. Victor, III, MD
11:55 AMLunch and Exhibits
 Plenary Session III: Innovations in Liver Transplantation
Moderators: Andres Duchini, MD; R. Mark Ghobrial, MD, PhD, FACS, FRCS (Ed); Robert S. McFadden, MD 
12:25 PMState of the Art Lecture III
The Future of Liver Transplantation 
Cristian Lupascu, MD, PhD
12:55 PMDEBATE
PRO: XenoTransplantation: Is Liver Xenotransplantation A Viable Option
Constance M. Mobley, MD, PhD, FACS
1:10 PMDEBATE
CON: XenoTransplantation: Is Liver Xenotransplantation A Viable Option
Chukwuma Egwim, MD
1:25 PMRebuttal 
1:35 PMLiving Donor Liver TransplantAshish Saharia, MD, FACS
2:05 PMHow Can We Expand Our Pool of Liver Donors? Mark J. Hobeika, MD, FACS
2:35 PMQuestion and Answer / Case Discussions – Putting it into PracticeAndres Duchini, MD; R. Mark Ghobrial, MD, PhD, FACS, FRCS (Ed); Robert S. McFadden, MD 
2:55 PMBreak and Exhibits
 Plenary Session IV: Liver Cancer - Current Concepts
Moderators: Maen Abdelrahim, MD, PhD, B Pharm; Kirk E. Heyne, MD; Milind M. Javle, MD
3:10 PMEpidemiology, Surveillance and Diagnosis of Hepatocellular Cancer Amit Singal, MD, MS
3:40 PMHepatocellular Carcinoma - Current and Future Medical OptionsSudha Kodali, MD, MSPH
4:10 PMState of the Art Lecture IV
Is the Management of Cholangiocarcinoma A Model for Personalized Medicine? 
Lewis R. Roberts, MB CHb, PhD
4:40 PMQuestion and Answer / Case Discussions – Putting it into PracticeMaen Abdelrahim, MD, PhD, B Pharm; Kirk E.  Heyne, MD, and Milind M. Javle, MD
5:00 PMClosing RemarksR. Mark Ghobrial, MD, PhD, FACS, FRCS (Ed)
5:05 PMAdjournment
LIVESTREAM (Virtual)

 

 

COURSE DIRECTOR
Victor Ankoma-Sey, MD, FACP, FAASLD
Director, Liver Transplant Program
Sherrie and Alan Conover Center for Liver Disease & Transplantation
Houston Methodist J.C. Walter Jr. Transplant Center
Director, Liver Associates of Texas, PA
 
GUEST FACULTY
Jasmohan S. Bajaj, MBBS, MD, MSc, FACG, AGAF, FAASLD, FRCP (London)
Tenured Professor of Medicine and Staff Physician
Virginia Commonwealth University Medical Center
Central Virginia VA Healthcare System
Richmond, Virginia
Naga P. Chalasani, MD
David W. Crabb Professor of Gastroenterology and Hepatology
Indiana Unviersity School of Medicine
Indianapolis, Indiana
Milind M. Javle, MD
Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, Texas
Cristian  Lupascu, MD, PhD
Professor of Surgery, University of Medicine and Pharmacy "Gr. T. Popa"
Head of Liver Transplantation Program
ProgramIasi, Romania
Mazen Noureddine, MD, MHSc
Director Houston Liver Institute
Houston, Texas
Lewis R. Roberts, MB CHb, PhD, FACP
Professor of Medicine
Division of Gastroenterology and Hepatology
Mayo Clinic College of Medicine
Rochester, Minnesota
Amit Singal, MD, MS
Professor of Medicine
Willis C. Maddrey, M.D. Distinguished Chair in Liver Disease
Chief of Hepatology and Medical Director, Liver Tumor Program
UT Southwestern Medical Center
Dallas, Texas
Norah A. Terrault, MD, MPH, FAASLD
Professor of Medicine
Chief, Division of GI and Liver: Neil Kaplowitz Chair in Liver Diseases
Keck School of Medicine of University of Southern California
Los Angeles, California
Hugo E. Vargas, MD
Director of Hepatology
Division of GI and Hepatology
Mayo Clinic
Phoenix, Arizona
Florence Wong, MD, FRACP, FRCPC
Professor of Medicine
University of Toronto
Toronto, Ontario, Canada
 
HOUSTON METHODIST FACULTY
Maen Abdelrahim, MD, PhD, B Pharm
Medical Director, Cockrell Center for Advanced Therapeutics, Phase I Program
Gastrointestinal Medical and Transplant Oncologist
Sherrie and Alan Conover Center for Liver Disease & Transplantation
Houston Methodist J.C. Walter Jr. Transplant Center
Assistant Professor of Medicine
Weill Cornell Medical College
Houston Methodist
Andrea Duchini, MD
Transplant Hepatology, Hepatology, Gastroenterology
Houston Methodist
Chukwuma Egwim, MD
Transplant Hepatologist
Sherrie and Alan Conover Center for Liver Disease & Transplantation
Houston Methodist J.C. Walter Jr. Transplant Center
Liver Associates of Texas, PA
Joseph S. Galati, MD
Medical Director, Sherrie and Alan Conover Center for Liver Disease & Transplantation
Houston Methodist J.C. Walter Jr. Transplant Center
Houston Methodist
Director, Liver Specialists of Texas
R. Mark Ghobrial, MD, PhD, FACS, FRCS (Ed)
J.C. Walter Jr. Presidential Distinguished Chair
Director, J.C. Walter Jr. Transplant Center
Director, Transplantation Research
Chief, Division of Transplantation, Department of Surgery
Professor of Surgery
Weill Cornell Medical College
Houston Methodist
Kirk E. Heyne, MD
Gastrointestinal Medical and Transplant Oncologist, Sherrie and Alan Conover Center for Liver Disease & Transplantation
Houston Methodist J.C. Walter Jr. Transplant Center
Assistant Professor of Medicine
Houston Methodist
Weill Cornell Medical College
Mark J. Hobeika, MD, FACS
Assistant Professor of Surgery, Academic Institute
Assistant Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College
Sudha Kodali, MD, MSPH
Transplant Hepatologist, Sherrie and Alan Conover Center for Liver Disease & Transplantation
Houston Methodist J.C. Walter Jr. Transplant Center
Associate Professor of Medicine
Houston Methodist
Robert S. McFadden, MD
Transplant Hepatologist, Sherrie and Alan Conover Center for Liver Disease & Transplantation
Houston Methodist J.C. Walter Jr. Transplant Center
Assistant Professor of Medicine
Houston Methodist
Weill Cornell Medical College
Constance M. Mobley, MD, PhD, FACS
Associate Director of Liver Transplantation
J.C. Walter Jr. Transplant Center
Associate Surgical Director of Liver Transplantation
Medical Director, Surgical & Liver ICU
Program Director, Surgical Critical Care Fellowship
Vice Chair Diversity, Equity and Community Integration
Houston Methodist Department of Surgery
Assistant Professor of Surgery
Houston Methodist
Weill Cornell Medical College
Adjunct Assistant Professor Texas A&M College of Medicine
Ashish Saharia, MD, FACS
Director, Liver Transplantation
Surgical Director of Liver Transplantation
Transplant and Hepatobiliary Surgeon, Sherrie and Alan Conover Center for Liver Disease & Transplantation
Houston Methodist J.C. Walter Jr. Transplant Center
Assistant Professor of Surgery
Houston Methodist
Weill Cornell Medical College
David W. Victor, III, MD
Transplant Hepatologist, Sherrie and Alan Conover Center for Liver Disease & Transplantation
Houston Methodist J.C. Walter Jr. Transplant Center
Associate Professor of Medicine
Houston Methodist
Weill Cornell Medical College

Available Credit

  • 8.50 AMA PRA Category 1 Credit

    Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    Houston Methodist designates this Live activity for a maximum of 8.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 8.50 Attendance
  • 8.66 Nursing Contact Hours

    Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

    Houston Methodist will award 8.66 Nursing Continuing Professional Development contact hours for this activity. Participants must attend the activity in its entirety and complete the continuing education evaluation.

  • 8.00 Social Work
    The program has been approved for 8.00 CE contact hours for Social Workers through the Texas State Board of Social Work Examiners.
  • 8.00 Transplant Coordinators
    The American Board for Transplant Certification (ABTC) has assigned the following Continuing Education Points for Transplant Certification (CEPTCs) to the following Houston Methodist Transplant Center educational program: Emerging Topics in Liver Disease Conference: Innovative Trends in Liver Health 2022 - LIVESTREAM (VIRTUAL ONLY) | Thu, 05/12/2022 - 10:00am | 8.00 Category 1 CEPTCs

COMMERCIAL SUPPORT

We gratefully acknowledge the following company for providing an educational grant to partially support this activity:

 

Salix

 

EXHIBITORS

We gratefully acknowledge the following companies for participating as exhibitors for this activity:

 

 
 

AbbVie

Dynavax

Eisai

Genentech

Gilead Sciences

Mallinkrodt

Salix

Takeda Pharmaceuticals

Price

Cost:
$300.00
Please login or register to take this course.

STEPS TO REGISTER:

  • STEP 1 - Choose the appropriate fee and click the "Add to Cart" button to complete the checkout process. 
  • STEP 2 - Once enrolled, click the link of the activity format for which you enrolled (the Status should say "In progress") and then click the "Take Course" button to begin the activity.

FEES

REGISTRATION TYPEFEE
Physician (Houston Methodist)$25
Physician (Private physician located within the Greater Houston Area)$300
Physician (Private physician located outside the Greater Houston Area)$50
Allied Health Care Professional$10
Resident / Fellow / StudentFree